Corrigendum to “Fibroblast growth factor-9 activates c-kit progenitor cells and enhances angiogenesis in the infarcted diabetic heart” (Oxidative Medicine and Cellular Longevity (2018) 2018 (6985498) DOI: 10.1155/2016/5810908);Fibroblast Growth Factor-9 Activates c-Kit Progenitor Cells and Enhances Angiogenesis in the Infarcted Diabetic Heart

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Singla, Dinender ^a   Wang, Jing ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; CHEMICAL ACTIVATION; ENDOTHELIAL CELLS; FIBROBLASTS; MAMMALS; PROTEINS; STEM CELLS;

CARDIAC FUNCTIONS; CELL ACTIVATION; EJECTION FRACTION; FIBROBLAST GROWTH FACTOR-9; LEFT VENTRICULAR; NEO-VASCULARIZATION; PROGENITOR CELL; VASCULAR SMOOTH MUSCLE CELLS;

CELL CULTURE;

ALPHA ACTIN; FIBROBLAST GROWTH FACTOR 9; STEM CELL FACTOR; FGF9 PROTEIN, MOUSE; STEM CELL FACTOR RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; ENDOTHELIUM CELL; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; QUANTITATIVE ANALYSIS; STEM CELL; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; DIABETIC CARDIOMYOPATHY; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PATHOLOGY;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; FIBROBLAST GROWTH FACTOR 9; MICE; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-KIT; STEM CELLS;

EID: 84949292738     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2018/6985498     Document Type: Erratum

References (41)

1. K. Y. Howangyin and J.-S. Silvestre, "Diabetes mellitus and ischemic diseases: molecular mechanisms of vascular repair dysfunction, "Arteriosclerosis, Thrombosis, andVascular Biology, vol. 34, no. 6, pp. 1126-1135, 2014.
2. H. M. Smith, M. Hamblin, and M. F. Hill, "Greater propensity of diabetic myocardium for oxidative stress after myocardial infarction is associated with the development of heart failure, " Journal of Molecular and Cellular Cardiology, vol. 39, no. 4, pp. 657-665, 2005.
3. G. Casella, S. Savonitto, F. Chiarella et al., "Clinical characteristics and outcome of diabetic patients with acute myocardial infarction. Data from the BLITZ-1 study, " Italian Heart Journal, vol. 6, no. 5, pp. 374-383, 2005.
4. C. E. Glass, P. K. Singal, and D. K. Singla, "Stem cells in the diabetic infarcted heart, " Heart Failure Reviews, vol. 15, no. 6, pp. 581-588, 2010.
5. A. Araszkiewicz, M. Janus, M. Prech et al., "Relations of diabetes mellitus, microvascular reperfusion and left ventricular remodelling in patients with acute myocardial infarction treated with primary coronary intervention, " Kardiologia Polska, vol. 72, no. 1, pp. 20-26, 2014.
6. B. Yan, L. S. Abdelli, and D. K. Singla, "Transplanted induced pluripotent stem cells improve cardiac function and induce neovascularization in the infarcted hearts of db/db mice, " Molecular Pharmaceutics, vol. 8, no. 5, pp. 1602-1610, 2011.
7. B. Yan andD. K. Singla, "Transplanted induced pluripotent stem cells mitigate oxidative stress and improve cardiac function through the akt cell survival pathway in diabetic cardiomyopathy, " Molecular Pharmaceutics, vol. 10, no. 9, pp. 3425-3432, 2013.
8. X. Hou, H. Zeng, X. He, and J.-X. Chen, "Sirt3 is essential for apelin-induced angiogenesis in post-myocardial infarction of diabetes, " Journal of Cellular andMolecularMedicine, vol. 19, no. 1, pp. 53-61, 2015.
9. J.-X. Chen andA. Stinnett, "Disruption ofAng-1/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 9, pp. 1606-1613, 2008.
10. Q.-H. Tuo, H. Zeng, A. Stinnett et al., "Critical role of angiopoietins/ Tie-2 in hyperglycemic exacerbation ofmyocardial infarction and impaired angiogenesis, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 294, no. 6, pp. H2547-H2557, 2008.
11. A. Beenken and M. Mohammadi, "The FGF family: biology, pathophysiology and therapy, " Nature Reviews Drug Discovery, vol. 8, no. 3, pp. 235-253, 2009.
12. N. Itoh and D. M. Ornitz, "Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease, " Journal of Biochemistry, vol. 149, no. 2, pp. 121-130, 2011.
13. M. J. Frontini, Z. Nong, R. Gros et al., "Fibroblast growth factor 9 delivery during angiogenesis produces durable, vasoresponsive microvessels wrapped by smoothmuscle cells, " Nature Biotechnology, vol. 29, no. 5, pp. 421-427, 2011.
14. D. Gay, O. Kwon, Z. Zhang et al., "Fgf9 from dermal T cells induces hair follicle neogenesis after wounding, " Nature Medicine, vol. 19, no. 7, pp. 916-923, 2013.
15. U. Pirvola, X. Zhang, J. Mantela, D. M. Ornitz, and J. Ylikoski, "Fgf9 signaling regulates inner ear morphogenesis through epithelial-mesenchymal interactions, " Developmental Biology, vol. 273, no. 2, pp. 350-360, 2004.
16. Y. Lin, L. Chen, C. Lin, Y. Luo, R. Y. L. Tsai, and F. Wang, "Neuron-derived FGF9 is essential for scaffold formation of Bergmann radial fibers and migration of granule neurons in the cerebellum, " Developmental Biology, vol. 329, no. 1, pp. 44-54, 2009.
17. M. Harada, H. Murakami, A. Okawa et al., "FGF9 monomerdimer equilibrium regulates extracellular matrix affinity and tissue diffusion, " Nature Genetics, vol. 41, no. 3, pp. 289-298, 2009.
18. J. S. Colvin, R. P. Green, J. Schmahl, B. Capel, and D. M. Ornitz, "Male-to-female sex reversal in mice lacking fibroblast growth factor 9, " Cell, vol. 104, no. 6, pp. 875-889, 2001.
19. M. Korf-Klingebiel, T. Kempf, K.-D. Schlüter et al., "Conditional transgenic expression of fibroblast growth factor 9 in the adult mouse heart reduces heart failure mortality after myocardial infarction, " Circulation, vol. 123, no. 5, pp. 504-514, 2011.
20. D. K. Singla, X. Long, C. Glass, R. D. Singla, and B. Yan, "Induced pluripotent stem (iPS) cells repair and regenerate infarcted myocardium, " Molecular Pharmaceutics, vol. 8, no. 5, pp. 1573-1581, 2011.
21. D. K. Singla, G. E. Lyons, and T. J. Kamp, "Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 293, no. 2, pp. H1308-H1314, 2007.
22. S. Fatma, D. E. Selby, R. D. Singla, and D. K. Singla, "Factors released from embryonic stem cells stimulate c-kit-FLK-1+ progenitor cells and enhance neovascularization, " Antioxidants and Redox Signaling, vol. 13, no. 12, pp. 1857-1865, 2010.
23. C. Glass and D. K. Singla, "MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart, "The American Journal of Physiology-Heart and Circulatory Physiology, vol. 301, no. 5, pp. H2038-H2049, 2011.
24. C. Emanueli and P. Madeddu, "Angiogenesis gene therapy to rescue ischaemic tissues: Achievements and future directions, " British Journal of Pharmacology, vol. 133, no. 7, pp. 951-958, 2001.
25. J. I. Barzilay, R. A. Kronmal, V. Bittner, E. Eaker, C. Evans, and E. D. Foster, "Coronary artery disease and coronary artery bypass grafting in diabetic patients aged ?65 years (report from the Coronary Artery Surgery Study [CASS] registry), " The American Journal of Cardiology, vol. 74, no. 4, pp. 334-339, 1994.
26. D. Tousoulis, N. Papageorgiou, E. Androulakis et al., "Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches, " Journal of the American College of Cardiology, vol. 62, no. 8, pp. 667-676, 2013.
27. A. B. Katwal and A. O. Dokun, "Peripheral arterial disease in diabetes: is there a role for genetics?" Current Diabetes Reports, vol. 11, no. 3, pp. 218-225, 2011.
28. M. S. Ruiter, J. M. Van Golde, N. C. Schaper, C. D. Stehouwer, and M. S. Huijberts, "Diabetes impairs arteriogenesis in the peripheral circulation: review of molecular mechanisms, " Clinical Science, vol. 119, no. 6, pp. 225-238, 2010.
29. L. L. Dunn, A. M. Buckle, J. P. Cooke, and M. K. C. Ng, "The emerging role of the thioredoxin system in angiogenesis, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 11, pp. 2089-2098, 2010.
30. T.-L. Yue, J. Chen, W. Bao et al., "In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor- agonist rosiglitazone, " Circulation, vol. 104, no. 21, pp. 2588-2594, 2001.
31. A. A. Kocher, M. D. Schuster, M. J. Szabolcs et al., "Neovascularization of ischemic myocardium by human bone-marrowderived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function, " Nature Medicine, vol. 7, no. 4, pp. 430-436, 2001.
32. G. Song, X. Li, Y. Shen et al., "Transplantation of iPSc restores cardiac function by promoting angiogenesis and ameliorating cardiac remodeling in a post-infarcted swine model, " Cell Biochemistry and Biophysics, vol. 71, no. 3, pp. 1463-1473, 2015.
33. A. A. Qayyum, A. B. Mathiasen, and J. Kastrup, "Stem cell therapy to treat heart ischaemia: implications for diabetes cardiovascular complications, " CurrentDiabetes Reports, vol. 14, article 554, 2014.
34. S.-W. Kim, M. Houge, M. Brown, M. E. Davis, and Y.-S. Yoon, "Cultured human bone marrow-derived CD31+ cells are effective for cardiac and vascular repair through enhanced angiogenic, adhesion, and anti-inflammatory effects, " Journal of theAmericanCollege ofCardiology, vol. 64, no. 16, pp. 1681-1694, 2014.
35. M. Clarke, M. Bennett, and T. Littlewood, "Cell death in the cardiovascular system, " Heart, vol. 93, no. 6, pp. 659-664, 2007.
36. J.-Y. Huang and J.-I. Chuang, "Fibroblast growth factor 9 upregulates heme oxygenase-1 and -glutamylcysteine synthetase expression to protect neurons from 1-methyl-4-phenylpyridinium toxicity, " Free Radical Biology andMedicine, vol. 49, no. 6, pp. 1099-1108, 2010.
37. L. DiNapoli, J. Batchvarov, and B. Capel, "FGF9 promotes survival of germ cells in the fetal testis, " Development, vol. 133, no. 8, pp. 1519-1527, 2006.
38. L. Ye, P. Zhang, S. Duval, L. Su, Q. Xiong, and J. Zhang, "Thymosin 4 increases the potency of transplanted mesenchymal stem cells for myocardial repair, " Circulation, vol. 128, no. 1, pp. S32-S41, 2013.
39. Y.-Y. He, Y. Wen, X.-X. Zheng, and X.-J. Jiang, "Intramyocardial delivery of HMGB1 by a novel thermosensitive hydrogel attenuates cardiac remodeling and improves cardiac function after myocardial infarction, " Journal of Cardiovascular Pharmacology, vol. 61, no. 4, pp. 283-290, 2013.
40. D. Tempel, M. de Boer, E. D. van Deel et al., "Apelin enhances cardiac neovascularization after myocardial infarction by recruiting aplnr+ circulating cells, " Circulation Research, vol. 111, no. 5, pp. 585-598, 2012.
41. X. Hu, R. Wu, Z. Jiang et al., "Leptin signaling is required for augmented therapeutic properties of mesenchymal stem cells conferred by hypoxia preconditioning, " Stem Cells, vol. 32, no. 10, pp. 2702-2713, 2014.